MétaCan
Menu
Back to cohort
Record W3094192068 · doi:10.1016/j.jtho.2020.09.027

Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC

2020· article· en· W3094192068 on OpenAlexafffund
Pierre-Olivier Gaudreau, Marcelo V. Negrão, K. G. Mitchell, Alexandre Reuben, Erin M. Corsini, Jun Li, Tatiana V. Karpinets, Qi Wang, Lixia Diao, Jing Wang, Lorenzo Federico, Edwin R. Parra-Cuentas, Roohussaba Khairullah, Carmen Behrens, Arlene M. Correa, Daniel R. Gomez, Latasha Little, Curtis Gumbs, Humam Kadara, Junya Fujimoto, Daniel J. McGrail, Ara A. Vaporciyan, Stephen G. Swisher, Garrett L. Walsh, Mara B. Antonoff, Annikka Weissferdt, Hai T. Tran, Emily Roarty, Cara Haymaker, Chantale Bernatchez, Jianhua Zhang, P. Andrew Futreal, Ignacio I. Wistuba, Tina Cascone, John V. Heymach, Boris Sepesi, Jianjun Zhang, Don L. Gibbons

Bibliographic record

VenueJournal of Thoracic Oncology · 2020
Typearticle
Languageen
FieldMedicine
TopicCancer Immunotherapy and Biomarkers
Canadian institutionsQueen's University
FundersJanssen BiotechFonds de Recherche du Québec - SantéUniversity of Texas MD Anderson Cancer CenterBill and Katie Weaver Charitable TrustEMD SeronoCancer Prevention and Research Institute of TexasGenentechInnovent BiologicsAstellas PharmaBayer FundTakeda Pharmaceutical CompanyRibon TherapeuticsMerckSpectrum PharmaceuticalsNorth Carolina GlaxoSmithKline FoundationNational Cancer InstituteBayerExelixisSanofiGlaxoSmithKlineSociety for Immunotherapy of CancerAstellas Pharma USEli Lilly and CompanyBristol-Myers SquibbAstraZenecaBoehringer Ingelheim
KeywordsMedicineInfiltration (HVAC)Cytotoxic T cellChemotherapyOncologyCellInternal medicineCancer researchIn vitro

Abstract

fetched live from OpenAlex

Introduction The combination of programmed cell death protein-1 or programmed death-ligand 1 immune checkpoint blockade and chemotherapy has revolutionized the treatment of advanced NSCLC, but the mechanisms underlying this synergy remain incompletely understood. In this study, we explored the relationships between neoadjuvant chemotherapy and the immune microenvironment (IME) of resectable NSCLC to identify novel mechanisms by which chemotherapy may enhance the effect of immune checkpoint blockade. Methods Genomic, transcriptomic, and immune profiling data of 511 patients treated with neoadjuvant chemotherapy followed by surgery (NCT) versus upfront surgery (US) were compared with determined differential characteristics of the IMEs derived from whole-exome sequencing (NCT = 18; US = 73), RNA microarray (NCT = 45; US = 202), flow cytometry (NCT = 17; US = 39), multiplex immunofluorescence (NCT = 10; US = 72), T-cell receptor sequencing (NCT = 16 and US = 63), and circulating cytokines (NCT = 18; US = 73). Results NCT was associated with increased infiltration of cytotoxic CD8 + T cells and CD20 + B cells. Moreover, NCT was associated with increases in CD8 + CD103 + and CD4 + CD103 + PD-1 + TIM3 − tissue resident memory T cells. Gene expression profiling supported memory function of CD8 + and CD4 + T cells. However, NCT did not affect T-cell receptor clonality, richness, or tumor mutational burden. Finally, NCT was associated with decreased plasma BDNF (TrkB) at baseline and week 4 after surgery. Conclusions Our study supports that, in the context of resectable NSCLC, neoadjuvant chemotherapy promotes antitumor immunity through T and B cell recruitment in the IME and through a phenotypic change toward cytotoxic and memory CD8 + and CD4 + memory helper T cells.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.355
Teacher spread0.335 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations106
Published2020
Admission routes2
Has abstractno

Explore more

Same venueJournal of Thoracic OncologySame topicCancer Immunotherapy and BiomarkersFrench-language works237,207